Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178714642> ?p ?o ?g. }
- W3178714642 endingPage "2189" @default.
- W3178714642 startingPage "2179" @default.
- W3178714642 abstract "Opioid-induced constipation is among the most common side effects associated with opioid use in patients with chronic non-cancer pain, and it can have a significant negative impact on health-related quality of life (QOL). This analysis evaluated the effect of naldemedine 0.2 mg on patient-reported outcomes in three phase 3 clinical studies.COMPOSE-1 and COMPOSE-2 were identical randomized, double-blind, placebo-controlled, parallel-group studies of 12 weeks' duration, allowing data to be integrated (n=1095). COMPOSE-3 was similar in design, but of 52 weeks' duration (n=1241). Patients were adults with chronic non-cancer pain who had been treated with opioid analgesics for ≥3 months and experiencing opioid-induced constipation. Patient-reported outcomes included Patient Assessment of Constipation Symptoms (PAC-SYM; 12 questions assessed on a 5-point Likert scale), PAC-QOL (28 questions assessed on a 5-point Likert scale), and Subject Global Satisfaction (measured on a 7-point Likert scale). The proportion of patients achieving a ≥1.5 improvement in PAC-SYM and PAC-QOL was calculated. The correlation between change in PAC-SYM and PAC-QOL scores and frequency of bowel movements was also explored.The proportion of PAC-SYM and PAC-QOL responders was significantly higher for naldemedine than for placebo at all assessed time points in COMPOSE-1/COMPOSE-2 (p<0.005 for both) and COMPOSE-3 (p<0.005 and p<0.0001, respectively). There was a statistically significant correlation between improvement in PAC-SYM/PAC-QOL and frequency of bowel movements at all time points (p≤0.0002). The majority of patients treated with naldemedine reported markedly or moderately improved satisfaction with constipation and abdominal symptoms on the Subject Global Satisfaction questionnaire.Naldemedine treatment was associated with a rapid and sustained clinically relevant improvement in patient-reported outcomes, indicating improvement in opioid-induced constipation-related symptoms and QOL.NCT01965158, NCT01993940, NCT01965652." @default.
- W3178714642 created "2021-07-19" @default.
- W3178714642 creator A5001729912 @default.
- W3178714642 creator A5020419303 @default.
- W3178714642 creator A5021286381 @default.
- W3178714642 creator A5029752566 @default.
- W3178714642 creator A5072458770 @default.
- W3178714642 creator A5083730981 @default.
- W3178714642 date "2021-07-01" @default.
- W3178714642 modified "2023-09-23" @default.
- W3178714642 title "Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies" @default.
- W3178714642 cites W1576185322 @default.
- W3178714642 cites W1966250447 @default.
- W3178714642 cites W1996075855 @default.
- W3178714642 cites W2021543354 @default.
- W3178714642 cites W2040109649 @default.
- W3178714642 cites W2061136386 @default.
- W3178714642 cites W2095025301 @default.
- W3178714642 cites W2105170404 @default.
- W3178714642 cites W2143221646 @default.
- W3178714642 cites W2145469804 @default.
- W3178714642 cites W2145998432 @default.
- W3178714642 cites W2176756126 @default.
- W3178714642 cites W2577281584 @default.
- W3178714642 cites W2617664403 @default.
- W3178714642 cites W2764265953 @default.
- W3178714642 cites W2786188339 @default.
- W3178714642 cites W2792218458 @default.
- W3178714642 cites W2911947138 @default.
- W3178714642 cites W2947635903 @default.
- W3178714642 cites W3159180772 @default.
- W3178714642 cites W2559827499 @default.
- W3178714642 doi "https://doi.org/10.2147/jpr.s282738" @default.
- W3178714642 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8291809" @default.
- W3178714642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34295186" @default.
- W3178714642 hasPublicationYear "2021" @default.
- W3178714642 type Work @default.
- W3178714642 sameAs 3178714642 @default.
- W3178714642 citedByCount "4" @default.
- W3178714642 countsByYear W31787146422022 @default.
- W3178714642 countsByYear W31787146422023 @default.
- W3178714642 crossrefType "journal-article" @default.
- W3178714642 hasAuthorship W3178714642A5001729912 @default.
- W3178714642 hasAuthorship W3178714642A5020419303 @default.
- W3178714642 hasAuthorship W3178714642A5021286381 @default.
- W3178714642 hasAuthorship W3178714642A5029752566 @default.
- W3178714642 hasAuthorship W3178714642A5072458770 @default.
- W3178714642 hasAuthorship W3178714642A5083730981 @default.
- W3178714642 hasBestOaLocation W31787146421 @default.
- W3178714642 hasConcept C105776082 @default.
- W3178714642 hasConcept C105795698 @default.
- W3178714642 hasConcept C121608353 @default.
- W3178714642 hasConcept C126322002 @default.
- W3178714642 hasConcept C141071460 @default.
- W3178714642 hasConcept C142724271 @default.
- W3178714642 hasConcept C159110408 @default.
- W3178714642 hasConcept C170493617 @default.
- W3178714642 hasConcept C1862650 @default.
- W3178714642 hasConcept C204787440 @default.
- W3178714642 hasConcept C27081682 @default.
- W3178714642 hasConcept C2775944032 @default.
- W3178714642 hasConcept C2779951463 @default.
- W3178714642 hasConcept C2781063702 @default.
- W3178714642 hasConcept C2781112942 @default.
- W3178714642 hasConcept C3017955636 @default.
- W3178714642 hasConcept C33923547 @default.
- W3178714642 hasConcept C526805850 @default.
- W3178714642 hasConcept C71924100 @default.
- W3178714642 hasConceptScore W3178714642C105776082 @default.
- W3178714642 hasConceptScore W3178714642C105795698 @default.
- W3178714642 hasConceptScore W3178714642C121608353 @default.
- W3178714642 hasConceptScore W3178714642C126322002 @default.
- W3178714642 hasConceptScore W3178714642C141071460 @default.
- W3178714642 hasConceptScore W3178714642C142724271 @default.
- W3178714642 hasConceptScore W3178714642C159110408 @default.
- W3178714642 hasConceptScore W3178714642C170493617 @default.
- W3178714642 hasConceptScore W3178714642C1862650 @default.
- W3178714642 hasConceptScore W3178714642C204787440 @default.
- W3178714642 hasConceptScore W3178714642C27081682 @default.
- W3178714642 hasConceptScore W3178714642C2775944032 @default.
- W3178714642 hasConceptScore W3178714642C2779951463 @default.
- W3178714642 hasConceptScore W3178714642C2781063702 @default.
- W3178714642 hasConceptScore W3178714642C2781112942 @default.
- W3178714642 hasConceptScore W3178714642C3017955636 @default.
- W3178714642 hasConceptScore W3178714642C33923547 @default.
- W3178714642 hasConceptScore W3178714642C526805850 @default.
- W3178714642 hasConceptScore W3178714642C71924100 @default.
- W3178714642 hasLocation W31787146421 @default.
- W3178714642 hasLocation W31787146422 @default.
- W3178714642 hasLocation W31787146423 @default.
- W3178714642 hasLocation W31787146424 @default.
- W3178714642 hasOpenAccess W3178714642 @default.
- W3178714642 hasPrimaryLocation W31787146421 @default.
- W3178714642 hasRelatedWork W1968042549 @default.
- W3178714642 hasRelatedWork W1971671270 @default.
- W3178714642 hasRelatedWork W1994149483 @default.
- W3178714642 hasRelatedWork W2066417915 @default.
- W3178714642 hasRelatedWork W2076235879 @default.